Toxoplasma gondii sag2 gene and mic3 gene recombinant adenovirus construction method, recombinant adenovirus and application

A recombinant adenovirus and gene recombination technology, applied in the field of genetic bioengineering, can solve the problem of no Toxoplasma gondii vaccine and other problems

Active Publication Date: 2022-05-10
SHENYANG AGRI UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no Toxoplasma vaccine available for humans, and there is only one veterinary Toxoplasma vaccine used in some countries: S48 attenuated strain vaccine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Toxoplasma gondii sag2 gene and mic3 gene recombinant adenovirus construction method, recombinant adenovirus and application
  • Toxoplasma gondii sag2 gene and mic3 gene recombinant adenovirus construction method, recombinant adenovirus and application
  • Toxoplasma gondii sag2 gene and mic3 gene recombinant adenovirus construction method, recombinant adenovirus and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] Below in conjunction with accompanying drawing and specific embodiment the present invention is described in further detail:

[0028] Compared with other vectors, adenovirus vectors have obvious advantages. There are many reports at home and abroad on the preparation of vaccines using adenoviruses as vectors. At present, the adenovirus vector system is quite mature. The research on T.gondii is also quite clear. It has been reported that other carriers are used to develop the genetically engineered vaccine of SAG2 or MIC3, and the immune challenge test proves that mice have a certain protective effect. Therefore, the present invention utilizes T.gondii SAG2 and MIC3 gene was used to construct a recombinant adenovirus Ad-SAG2-MIC3-EGFP, so as to develop a bivalent genetically engineered live carrier vaccine for preventing toxoplasmosis.

[0029] The method for constructing recombinant adenovirus Ad-SAG2-MIC3-EGFP of T.gondii SAG2 gene and MIC3 gene of the present inventio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for constructing a recombinant adenovirus of Toxoplasma gondii SAG2 (surface antigen 2) gene and MIC3 (microbody protein 3) gene, and the recombinant adenovirus and application. from Toxoplasma gondii The SAG2 gene and the MIC3 gene were amplified from the RH strain, the obtained target gene was cloned into the shuttle vector pHBAd-EF1a-MCS-3flag-CMV-EGFP, and the recombinant adenovirus shuttle plasmid pHBAd- HEK293A cells were co-transfected with SAG2‑MIC3‑EGFP and the adenovirus large backbone pBHGlox(delta)E1,3Cre, and recombinant adenovirus Ad‑SAG2‑MIC3‑EGFP containing SAG2 gene and MIC3 gene was obtained by recombination and packaging; After immunizing Balb / c mice, the antibody level of the mice was significantly increased, the proportion of activated TCL and Th lymphocytes was significantly increased, and cytokines such as IF-γ, IL-6 and TN-α were significantly increased, and the levels of Balb / c were significantly increased. Mice have a certain protective effect.

Description

technical field [0001] The invention belongs to the field of genetic bioengineering, and relates to a method for constructing a recombinant adenovirus, specifically, a method for constructing a recombinant adenovirus using Toxoplasma gondii SAG2 gene and MIC3 gene, and the recombinant adenovirus and its application. Background technique [0002] Toxoplasma gondii (Toxoplasma gondii) is an obligate intracellular nucleated parasitic protozoan. It is a serious food-borne zoonotic parasite that can infect more than 200 species of animals including livestock, poultry and humans. The human infection rate is about 25% to 50%, and there are about 500 to 1 billion people infected with toxoplasmosis in the world; the lethal outbreak of toxoplasma can cause a large number of livestock and poultry deaths, and the death rate of pigs can reach 60%. Toxoplasma gondii not only directly endangers the development of animal husbandry and product quality and safety, but also can cause public he...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/861C12N15/66C12N7/01A61K39/002A61P33/02
CPCA61K39/002A61P33/02C12N7/00C12N15/66C12N15/86C12N2710/10021C12N2710/10043A61K2039/53
Inventor 陈启军张东超姜宁
Owner SHENYANG AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap